WallStreetZen

NYSE: ABBV
AbbVie Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABBV

Based on 6 analysts offering 12 month price targets for AbbVie Inc.
Min Forecast
$116.00+9.01%
Avg Forecast
$134.67+26.55%
Max Forecast
$148.00+39.08%

Should I buy or sell ABBV stock?

Based on 6 analysts offering ratings for AbbVie Inc.
Strong Buy
Strong Buy
2 analysts 33.33%
Buy
4 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABBV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
SVB Leerink
Top 20%
81
BuyMaintains$148.00+39.08%2021-08-20
Mizuho
Bottom 13%
13
Strong BuyMaintains$131.00+23.11%2021-08-02
BMO Capital
Top 49%
52
BuyMaintains$129.00+21.23%2021-05-03
Anonymous
SVB Leerink
BuyMaintains$144.00+35.33%2021-03-30
SVB Leerink
Top 45%
56
BuyMaintains$140.00+31.57%2021-02-04
Morgan Stanley
Top 26%
75
Strong BuyMaintains$116.00+9.01%2021-01-28

1 of 1

Forecast return on equity

Is ABBV forecast to generate an efficient return?
Company
177.34%
Industry
74.41%
Market
2,556.64%
ABBV's Return on Equity is forecast to be high in 3 years (177.34%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABBV forecast to generate an efficient return on assets?
Company
15.06%
Industry
16.39%
Market
1,250.14%
ABBV is forecast to generate lower Return on Assets (15.06%) than the US Drug Manufacturers - General industry average (16.39%)
Forecast

ABBV earnings per share forecast

What is ABBV's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$12.64+244.52%
Avg 2 year Forecast
$13.90+278.71%
Avg 3 year Forecast
$11.98+226.32%
ABBV's earnings are forecast to grow at an exceptional rate of 51.44% per year
Forecast

ABBV revenue forecast

What is ABBV's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$56.4B+5.05%
Avg 2 year Forecast
$60.1B+11.92%
Avg 3 year Forecast
$56.5B+5.2%
ABBV's revenue is forecast to grow at a rate of 2.43% per year, which is not exceptional
Forecast

ABBV earnings growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
51.44%
Industry
22.05%
Market
18.71%
ABBV's earnings are forecast to grow faster (51.44% per year) than the US Drug Manufacturers - General industry average (22.05%)
Forecast
ABBV's earnings are forecast to grow faster (51.44% per year) than the US market average (18.71%)
Forecast
ABBV's earnings are forecast to grow faster (51.44% per year) than the risk-free savings rate (1.3%)
Forecast

ABBV revenue growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
2.43%
Industry
4.53%
Market
12.32%
ABBV's revenues are forecast to grow slower (2.43% per year) than the US Drug Manufacturers - General industry average (4.53%)
Forecast
ABBV's revenues are forecast to grow slower (2.43% per year) than the US market average (12.32%)
Forecast

AbbVie Stock Forecast FAQ

Is AbbVie Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock.

Out of 6 analysts, 2 (33.33%) are recommending ABBV as a Strong Buy, 4 (66.67%) are recommending ABBV as a Buy, 0 (0%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell.

What is ABBV's earnings growth forecast for 2021-2023?

(NYSE: ABBV) AbbVie's forecast annual earnings growth rate of 51.44% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 22.05%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.71%.

AbbVie's earnings in 2021 is $6,663,000,000.On average, 8 Wall Street analysts forecast ABBV's earnings for 2021 to be $22,343,813,992, with the lowest ABBV earnings forecast at $22,125,037,661, and the highest ABBV earnings forecast at $22,619,846,810. On average, 8 Wall Street analysts forecast ABBV's earnings for 2022 to be $24,561,619,284, with the lowest ABBV earnings forecast at $23,326,717,022, and the highest ABBV earnings forecast at $25,977,480,320.

In 2023, ABBV is forecast to generate $21,163,694,171 in earnings, with the lowest earnings forecast at $20,004,427,022 and the highest earnings forecast at $22,107,365,905.

What is ABBV's revenue growth forecast for 2021-2023?

(NYSE: ABBV) AbbVie's forecast annual revenue growth rate of 2.43% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.32%.

AbbVie's revenue in 2021 is $53,729,000,000.On average, 5 Wall Street analysts forecast ABBV's revenue for 2021 to be $99,743,734,277,889, with the lowest ABBV revenue forecast at $98,712,675,713,743, and the highest ABBV revenue forecast at $100,773,184,712,300. On average, 5 Wall Street analysts forecast ABBV's revenue for 2022 to be $106,268,354,868,745, with the lowest ABBV revenue forecast at $103,752,660,331,007, and the highest ABBV revenue forecast at $110,190,463,122,328.

In 2023, ABBV is forecast to generate $99,883,652,167,810 in revenue, with the lowest revenue forecast at $96,862,425,259,984 and the highest revenue forecast at $104,381,757,148,644.

What is ABBV's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABBV) forecast ROA is 15.06%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.39%.

What is ABBV's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $134.67, with the highest ABBV stock price forecast at $148.00 and the lowest ABBV stock price forecast at $116.00.

On average, Wall Street analysts predict that AbbVie's share price could stay at $134.67 by Aug 20, 2022. The average AbbVie stock price prediction forecasts a potential downside of N/A from the current ABBV share price of $106.41.

What is ABBV's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABBV) AbbVie's current Earnings Per Share (EPS) is $3.67. On average, analysts forecast that ABBV's EPS will be $12.64 for 2021, with the lowest EPS forecast at $12.52, and the highest EPS forecast at $12.80. On average, analysts forecast that ABBV's EPS will be $13.90 for 2022, with the lowest EPS forecast at $13.20, and the highest EPS forecast at $14.70. In 2023, ABBV's EPS is forecast to hit $11.98 (min: $11.32, max: $12.51).

What is ABBV's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABBV) forecast ROE is 177.34%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.